Predicting Tissue of Origin from Bulk Tumor Gene Expression using a Pre-trained Transformer Model
Abstract
Identifying the tissue of origin for cancers is essential for enhancing diagnostic precision, selecting effective treatments, and guiding clinical decision-making. In this study, we developed a predictive model to classify the tissue of origin across various cancer types. Using a dataset with 10,300 samples from 32 unique tissue types, the model achieved an overall accuracy of 88% in distinguishing among all 32 classes, with an average accuracy of 99.2% within each class. When tested on metastatic skin tumors, it reached an accuracy of 87%, underscoring its potential in addressing challenging metastatic cases. These results demonstrate the models reliability in oncology applications, offering a promising tool for improving diagnostic accuracy and supporting personalized cancer treatment strategies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cancer Diagnostics using Machine Learning of Tumor- and Tissue- Specific RNA Transcripts
Zhiao Chen, Jiawei Tang, … Xianghuo He·bioRxiv·May 27, 2025
- Pan-cancer machine learning predictors of primary site of origin and molecular subtype
William F. Flynn, Sandeep Namburi, … Joshy George·bioRxiv·Jul 5, 2018
- Deep Discriminative Fine-Tuning for Cancer TypeClassification
A. Harley·bioRxiv·Nov 13, 2019
- A Transformer-Based Approach to Survival Outcome Prediction
Ted Mellors, Matt Schneider, Mehran Spitmann·bioRxiv·Nov 3, 2024
- GeneBag: training a cell foundation model for broad-spectrum cancer diagnosis and prognosis with bulk RNA-seq data
Yuhu Liang, Dan Li, … Kun Tang·bioRxiv·Jun 27, 2024
- Development and Validation of OncoOrigin: An Integrative AI Tool for Primary Cancer Site Prediction
Petar Brlek, Luka Bulić, … Dragan Primorac·medRxiv·Nov 29, 2024